Loading interface...

Olmepath-CH 20 Tablet

Manufactured byPROQOL HEALTHCARE LTD
ContainsOlmesartan (20 mg) + Chlorthalidone (12.5 mg)
Description
Olmepath-CH 20 Tablet is a combination of Chlorthalidone and Olmesartan. It is used in the treatment of hypertension (high blood pressure). This medicine works by relaxing the blood vessels and also increasing the water and sodium excretion from the body. Thus it promotes the smooth flow of blood and also allows your heart to pump blood more efficiently. Olmepath-CH 20 Tablet has some side effects like cough, nausea, headache, diarrhoea, dizziness, and upset stomach. This medicine may cause you to urinate more often as it works by removing extra water from your body. Drink plenty of fluids while taking this medicine to prevent getting dehydrated. If any of these side effects do not resolve with time or get worse, consult your doctor immediately. Avoid taking this medicine if you are allergic to it. Olmepath-CH 20 Tablet may be taken in the morning to avoid frequent urination at night. Do not stop taking this medicine suddenly as it can cause your blood pressure to rise, thereby increasing the risk of heart attack and stroke (a condition that occurs due to reduced oxygen supply to the brain). Olmepath-CH 20 Tablet should be used with caution if you have kidney or liver problems, or diabetes. Inform your doctor if you are taking any other medicine before starting the treatment. Olmepath-CH 20 Tablet is not recommended for use in children below 18 years of age due to lack of safety and efficacy data. Consult your doctor if you are pregnant, planning a pregnancy, or are breastfeeding.

Side effects

Major & minor side effects for Olmepath-CH 20 Tablet

  • Body pain
  • Headache
  • Chills
  • Unusual tiredness and weakness
  • Blood in urine
  • Joint pain
  • Bladder pain
  • Diarrhoea
  • Dry mouth
  • Increased urination
  • Skin rash
  • Low blood pressure
  • Loss of appetite
  • Nausea
  • Dizziness
  • Blurred vision

Uses of Olmepath-CH 20 Tablet

What is it prescribed for?

  • Hypertension
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time taken for Olmepath-CH 20 Tablet to start its action is not known.
  • How long do the effects of this medicine last?
    The effect of Olmepath-CH 20 Tablet may last for an average duration of 24 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Avoid consumption of alcohol while you are taking Olmepath-CH 20 Tablet as it may further lower your blood pressure and make you feel dizzy or lightheaded.
  • Is this a habit forming medicine?
    Olmepath-CH 20 Tablet has no habit-forming tendency.
  • Can this medicine be taken during pregnancy?
    Olmepath-CH 20 Tablet is not recommended for use during pregnancy as it may harm your foetus. Consult your doctor if you are pregnant.
  • Can this medicine be taken while breast-feeding?
    Olmepath-CH 20 Tablet may pass into breastmilk. Hence, consult your doctor if you are breastfeeding.

Allergy

Avoid taking Olmepath-CH 20 Tablet if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling of the face/tongue/throat, breathing difficulty, etc.

Anuria

Anuria is a condition in which the kidneys are unable to produce urine. Olmepath-CH 20 Tablet is not recommended for use if you have anuria as it may further damage your kidneys.

Aliskiren

Coadministration of Olmepath-CH 20 Tablet and Aliskiren (a medicine used to reduce blood pressure) is not recommended if you have diabetes (high blood sugar levels) and/or moderate to severe kidney impairment as it may increase the risk of kidney damage.
Warnings for special population

Pregnancy

Olmepath-CH 20 Tablet is not recommended for use during pregnancy as it may harm your foetus. Consult your doctor if you are pregnant.

Breast-feeding

Olmepath-CH 20 Tablet may pass into breastmilk. Hence, consult your doctor if you are breastfeeding.
General warnings

Volume and electrolyte disturbances

Olmepath-CH 20 Tablet may alter the blood volume and electrolyte levels. This may cause dizziness, dry mouth, thirst, weakness, acid-base imbalance (abnormality in the human body to balance between acid and base), etc. Hence, your blood pressure and electrolyte levels will be periodically monitored by your doctor while you are taking this medication.

Driving or operating machines

Use of Olmepath-CH 20 Tablet may cause dizziness or fatigue in some cases. Hence, avoid performing activities such as driving or operating machines if you experience any of these symptoms.

Hypotension

Olmepath-CH 20 Tablet should be used with caution as it may cause symptomatic hypotension (low blood pressure), especially if you have volume depletion (excess loss of salt and fluid from the body due to severe diarrhoea, vomiting, burns and kidney problems leading to reduced fluid volume). Your doctor may correct this condition before initiating treatment with Olmepath-CH 20 Tablet.

Use in Children

Olmepath-CH 20 Tablet is not recommended for use in children below 18 years of age since the safety and efficacy data for use are not clinically established.

Missed Dose

If you miss a dose of Olmepath-CH 20 Tablet, take it as soon as you remember. If it is time for your next scheduled dose, then skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Never take more than the prescribed dose of Olmepath-CH 20 Tablet. Seek immediate medical attention in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Avoid consumption of alcohol while you are taking Olmepath-CH 20 Tablet as it may further lower your blood pressure and make you feel dizzy or lightheaded.
Interaction with Medicine

Dexamethasone

Insulin

Diclofenac

Disease interactions

Diabetes

Olmepath-CH 20 Tablet should be used with caution if you have diabetes (high blood sugar levels) as this medicine may alter blood sugar levels.

Hyperuricaemia

Olmepath-CH 20 Tablet should be used with caution if you have hyperuricaemia (increased uric acid levels in the blood). This medicine decreases uric acid excretion and may further increase the levels of uric acid in your blood.

Hyperlipidaemia

Olmepath-CH 20 Tablet may increase the blood cholesterol and fats levels. Hence, it should be used with caution if you have hyperlipidaemia (a condition that leads to high levels of cholesterol and fats in the blood).
Food interactions
Information not available.
Lab interactions
Information not available.
Take Olmepath-CH 20 Tablet with or without food as instructed by your doctor. Avoid taking more or less than the prescribed dose. Do not break, crush or chew the tablet. Take this medicine at the same time every day as it will help you to remember. This medicine can make you feel dizzy. Hence, get up slowly from a sitting or lying position. Your doctor may suggest regular tests to monitor your blood sugar, blood cholesterol, and fat levels during treatment with this medicine. Eat a healthy balanced diet and exercise regularly to get maximum benefits from the treatment.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Olmepath-CH 20 Tablet is a combination of Chlorthalidone and Olmesartan. Chlorthalidone increases the excretion of water and sodium from the kidneys via urine. Olmesartan relaxes and widens your blood vessels. This lowers your blood pressure and makes it easier for your heart to pump blood throughout your body.
Legal Status

Unknown

Unknown

Unknown

Unknown

Classification

Category

Thiazide diuretics, Angiotensin receptor blockers, Antihypertensive combinations

Schedule

Schedule H

Drugs, H., 2021. Chlorthalidone: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 5 October 2021].

https://medlineplus.gov/druginfo/meds/a682342.html>

Drugs, H., 2021. Olmesartan: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 5 October 2021].

https://medlineplus.gov/druginfo/meds/a603006.html>

Dailymed.nlm.nih.gov. 2021. DailyMed - CHLORTHALIDONE tablet. [online] Available at: < [Accessed 5 October 2021].

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=193c85ba-43c2-4be2-82cf-7b394a83390e>

Medicines.org.uk. 2021. Olmesartan 10mg Film-coated Tablets - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 5 October 2021].

https://www.medicines.org.uk/emc/medicine/33000>

Accessdata.fda.gov. 2021. [online] Available at: < [Accessed 20 October 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019574s016lbl.pdf>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 21 Oct 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.